Neoadjuvant and Adjuvant Chemotherapy Treatment Patterns Among Older Triple-negative and HER2-positive Breast Cancer Patients with Comorbidities

被引：0
|
作者：
Tamirisa, Nina [1 ]
Dong, Wenli [1 ]
Shen, Yu [1 ]
Shaitelman, Simona [1 ]
Babiera, Gildy [1 ]
Bedrosian, Isabelle [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1387856
引用
收藏
页码：S315 / S316
页数：2
相关论文
共 50 条
  • [1] Sequencing of chemotherapy and surgery among older triple-negative and HER2-positive breast cancer patients with comorbidities
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [2] Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer
    Goncalves, Anthony
    BULLETIN DU CANCER, 2016, 103 (06) : S76 - S89
  • [3] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
    Leon-Ferre, Roberto A.
    Hieken, Tina J.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2111 - 2119
  • [4] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
    Roberto A. Leon-Ferre
    Tina J. Hieken
    Judy C. Boughey
    Annals of Surgical Oncology, 2021, 28 : 2111 - 2119
  • [5] Neoadjuvant chemotherapy for triple-negative and HER2-positive breast cancer: Striving for the standard of care
    Roberts, Amanda
    Coburn, Natalie
    Wright, Frances
    Nguyen, Lena
    Gandhi, Sonal
    Hallet, Julie
    Jerzak, Katarzyna
    Eisen, Andrea
    Wilton, Andrew
    Hong, Nicole Look
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 199 - 200
  • [6] Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer
    Tamirisa, Nina
    Dong, Wenli
    Shen, Yu
    Lin, Heather
    Shaitelman, Simona F.
    Babiera, Gildy
    Bedrosian, Isabelle
    NPJ BREAST CANCER, 2025, 11 (01)
  • [7] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [8] Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancer
    Miglietta, Federica
    Dieci, Maria Vittoria
    Griguolo, Gaia
    Guarneri, Valentina
    CANCER TREATMENT REVIEWS, 2021, 98
  • [9] Use of adjuvant chemotherapy and outcomes in women age 70 and older with HER2-positive (HER2+) or triple-negative (TN) breast cancer (BC)
    Hsu, Tina
    Speers, Caroline
    Tyldesley, Scott
    Chia, Stephen K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
    Harbeck, Nadia
    BREAST, 2022, 62 : S12 - S16
12345